Pixelence News
Milestones, partnerships, and breakthroughs on our mission to make brain MRI safer and more accessible.
2026
Selected to Pitch at the 2026 SelectUSA Investment Summit — Washington D.C.
Pixelence has been selected to pitch at the 2026 SelectUSA Investment Summit — the highest-profile foreign direct investment event in the United States, hosted by the U.S. Department of Commerce at National Harbor, Maryland. Out of a large pool of competitive applicants, Pixelence was chosen to present in the Health Pitching Session on Monday, May 4, 2026, in front of over 5,500 attendees representing investors and organisations from 100+ countries.
Session winners advance to the World Finals on May 5, 2026 — a global stage bringing together top startups from every industry pitching session. This recognition underscores Pixelence’s growing international momentum as we advance our gadolinium-free contrast MRI synthesis technology toward clinical deployment.
Pixelence Exhibits & Pitches at SusHi Tech Tokyo 2026
Pixelence is participating as an official exhibitor at SusHi Tech Tokyo 2026, one of Asia’s largest startup and innovation events hosted by the Tokyo Metropolitan Government. Bringing together over 700 startups, 60,000 participants, and 10,000 business meetings across three days at Tokyo Big Sight, the event showcases breakthrough technologies in AI, Robotics, Resilience, and Entertainment.
In addition to exhibiting, Pixelence is competing in the SusHi Tech Challenge pitching competition, presenting our gadolinium-free contrast MRI synthesis technology to an international audience of investors, healthcare leaders, and industry partners.
Patent Filed for Gadolinium-Free Contrast MRI Synthesis
Pixelence has officially filed a patent for an AI system that generates brain contrast-enhanced MRI images without gadolinium contrast agents. The technology combines multi-sequence non-contrast MRI, deep pathology segmentation, and conditional generative models to create synthetic contrast — prioritising accuracy in pathology-positive regions.
This milestone brings us closer to making neuro-oncology imaging safer, faster, and more accessible for patients and hospitals where contrast administration poses risks or logistical challenges.
Read on LinkedIn →Selected to Pitch at SelectUSA Tech — Malaysia Session
Pixelence was selected as one of six Malaysian startups to pitch at the SelectUSA Tech virtual session, presenting our non-invasive brain MRI contrast enhancement solution to an international panel of judges. The winner receives a complimentary ticket to the SelectUSA Investment Summit in Maryland, USA — the highest-profile US event for promoting foreign direct investment.
Read on LinkedIn →Top 3 at NEXEA Selangor Life Sciences Accelerator
Pixelence was selected as a Top 3 startup in the NEXEA Selangor Life Sciences Accelerator finals, pitching alongside nine other life sciences and digital health teams. Alongside fellow winners BioLoop and PlusVibes, Pixelence received RM 20,000 in funding to further advance our AI-powered medical imaging solutions.
Special thanks to mentors Ben Lim, Dr. Inky, and Vykintas Mineikis, and to NEXEA and Invest Selangor Berhad for their continued support of Malaysia's life sciences ecosystem.
Read on LinkedIn →Featured on the Ctrl Alt Deliver Podcast
Our founder Raheel Zubairi joined host Yasin on the Ctrl Alt Deliver podcast to discuss how AI transitions from pilot to production in healthcare, why AI initiatives stall before reaching real-world deployment, and the unique challenges that arise when modern AI systems meet legacy hospital environments.
Read on LinkedIn →2025
Top 6 at Selangor Deep Tech Xccelerator (Deep-X) Final Demo Day
Pixelence earned a Top 6 position at the Deep-X Final Demo Day held at KLCC Hall 6, Kuala Lumpur, competing against 12 deep tech startups. Judges from Endeavour, Gobi Partners, Artem Ventures, Cradle, and MDEC evaluated the pitches.
As a result, Pixelence was selected to represent Malaysia on an industry trip to South Korea (October 19–26, 2025) to advance AI-powered medical imaging within the global health tech ecosystem.
Read on LinkedIn →Finalist at Startup World Cup West Malaysia Finals 2025
Pixelence was selected as one of ten finalists to pitch at the Startup World Cup West Malaysia Finals 2025, held at Asia School of Business, Kuala Lumpur. Competing against nearly 200 nationwide applicants, Pixelence presented its AI-powered contrast imaging technology that replaces toxic chemical dyes — cutting costs by 60% and eliminating side effects in medical diagnostics. The event was organised by Growth Charger and supported by Cradle Fund Sdn Bhd.
Selected for Cyberview Living Lab Accelerator Cohort 19 Demo Day
Pixelence was selected as one of ten startups to present at the Cyberview Living Lab Accelerator (CLLA) Cohort 19 Demo Day, marking the programme's 10th anniversary. Out of approximately 90 applicants, 24 startups were initially chosen, with Pixelence advancing through the five-month support programme to the final showcase. Since its inception in 2014, the CLLA has empowered over 129 startups, securing more than US$58.40 million in investments.
2024
BrainEnhance Technology Officially Introduced
Pixelence publicly introduced BrainEnhance — our AI software that generates synthetic contrast-enhanced MRI scans from native non-contrast sequences using a generative U-Net architecture with attention blocks. The technology reduces imaging costs by 30%, enhances patient safety by eliminating gadolinium contrast agent risks, and enables more frequent monitoring for patients needing regular scans.
Read on LinkedIn →